Investor

H.I.G. BioHealth

Last cheque observed Feb 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietNew fund $129M, Nov 2019VC firm

Series A

Cheques on record
0%of best year0cheques in 12 months, 2 on record
Since the last cheque2807days00hrs00min00sec
Median round$120MRounds led0 of 2
Pitch H.I.G. BioHealth

H.I.G. BioHealth highlights

  1. 01

    2 rounds on record

  2. 02

    Mostly Series A: 100% of its rounds

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first2 appearances

  1. 2019

    1 round

  2. Feb
    Arvelle TherapeuticsSeries A · CH · European-biotechnology$180MWith 4 others
  3. 2018

    1 round

  4. May
    NeuranaSeries A · US · FinSMEs$60MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration3 named

ATAnthony TamerCO-PRESIDENT AND DIRECTOR OF THE MANAGERiFiling they signed
RSRichard SiegelVP AND GENERAL COUNSEL OF THE MANAGERiFiling they signed
SMSami MnaymnehCO-PRESIDENT AND DIRECTOR OF THE MANAGERiFiling they signed

We also hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Recently backed

The latest companies H.I.G. BioHealth put money into.

Arvelle Therapeutics$180M · Feb 2019

Quick answers about H.I.G. BioHealth

What does H.I.G. BioHealth invest in?

H.I.G. BioHealth invests most often at Series A (100% of the rounds on record).

How active is H.I.G. BioHealth?

2 investments on record, 0 of them in the last 12 months. The most recent was in Feb 2019.

What has H.I.G. BioHealth invested in recently?

Its most recent investments on record: Arvelle Therapeutics (Series A, Feb 2019) and Neurana (Series A, May 2018).

How big are H.I.G. BioHealth's cheques?

The median round it joins is $120M.

Is H.I.G. BioHealth investing now?

No investments in the last 12 months; the latest was in Feb 2019.

What kind of investor is H.I.G. BioHealth?

H.I.G. BioHealth is a VC firm.

Has H.I.G. BioHealth raised a new fund?

Its latest fund filing with the SEC was in Nov 2019, reporting $129M raised.

Where does this information on H.I.G. BioHealth come from?

From 2 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it